Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000517088 | SCV000615013 | uncertain significance | not specified | 2017-02-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000654079 | SCV000775969 | uncertain significance | Charcot-Marie-Tooth disease type 4 | 2017-10-24 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with methionine at codon 143 of the SBF2 protein (p.Val143Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs142469360, ExAC 0.04%). This variant has not been reported in the literature in individuals with SBF2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |